Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799201 · ClinicalTrials.gov registry record · Phase 4
Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients
A Phase 4 study, sponsored by CAMC Health System.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT00799201 is a Phase 4 study that was terminated before completion, run by CAMC Health System. The registered enrollment target is 3 participants.
The verdict
NCT00799201, a Phase 4 study, was terminated before completion, sponsored by CAMC Health System.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if enteral naloxone is more effective than a traditional bowel regimen in the prevention and treatment of constipation and impaired gastric motility in critically ill trauma patients.
Interventions
- DRUG Naloxone and Docusate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799201
The ClinicalTrials.gov registry entry for NCT00799201 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naloxone and Docusate is the first listed.
NCT00799201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799201 about?
NCT00799201 is a clinical study titled "Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients". The purpose of this study is to determine if enteral naloxone is more effective than a traditional bowel regimen in the prevention and treatment of constipation and impaired gastric motility in critically ill trauma patients.
What is the current status of trial NCT00799201?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2007-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00799201?
The interventions under investigation include: Naloxone and Docusate (DRUG).
Who is sponsoring clinical trial NCT00799201?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.